Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-11

Clinical Trial Update: A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

View source ↗

Summary

This completed UK clinical trial evaluated recombinant von Willebrand factor used on demand and for prevention and treatment of bleeding during and after surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant von Willebrand factor (recombinant von Willebrand factor)

Snippet

Sponsor: Takeda | Conditions: Von Willebrand Disease (VWD) | Status: COMPLETED